SRC and pulmonary fibrosis: There was only partial inhibition of lung injury and fibrogenesis through Src knockout and pharmacologic inhibition with nintedanib suggested that there are other potential mechanisms, such as PDGFR, FGFR and VEGFR pathways contributing to MV‐induced EMT and pulmonary fibrosis (Fig. S2).